An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity - Test2 - elhamkhani - TriplyDB

An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity

An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity

http://www.wikidata.org/entity/Q28275948

about

Multiple sclerosis-a quiet revolution Current perspectives on systems immunology approaches to rheumatic diseases.Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity Individualized medicine from prewomb to tomb Phenomapping for novel classification of heart failure with preserved ejection fraction.Induction of a unique isoform of the NCOA7 oxidation resistance gene by interferon β-1b.Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis.Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countries.Systems approaches to human autoimmune diseases.Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma.Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis.Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis.Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts.MS AHI1 genetic risk promotes IFNγ+ CD4+ T cells.

P2860

Q26826930-FFD47674-6D16-44E5-9E5A-1C5787CCEFED Q27687400-5D58B057-044E-451B-A873-818C60E77506 Q28081150-4854B8CF-1ED4-45B6-A60B-274E4EA62E91 Q28261215-76B818E8-F67F-4513-A07E-1BB90E3B07B4 Q29525070-27D916AE-0E81-41A8-9CF5-84536200E0A7 Q34995857-3DFFC8FA-5E30-41B5-87E8-4B93021FD278 Q35148941-5CD41621-5522-4FEC-84DC-69CC2F16B384 Q35631087-2A80EBC3-1EC0-4FA2-ABF9-13BC197ABAA6 Q37050779-8CAADF89-B77C-4027-8D04-288F8D2BBE30 Q37193914-4E6C78BD-EA06-4135-BF9A-A705C477B5B8 Q37367956-01A8B6B9-399F-4421-98B1-76F862EE1C91 Q37424282-E44FF026-4FC6-46E6-BB68-DD0770237B4F Q37584747-6718E6C9-29D3-4AFA-AD0D-322D2847D644 Q38837469-EEB11BDC-4698-4983-B439-BF969286294C Q38984981-8F9B3747-1D4D-4C4B-8F10-79B7D3461EA4 Q39160992-1874F9E7-AF23-423C-90FA-35FDAEF800A4 Q40085017-15167778-634F-4DE1-B9C5-1B4B089C4FB2 Q41830012-0B719B98-67BC-4B32-8E54-F1A35A8A6BB9 Q43607544-70F5016A-82B6-4205-8716-8B2185072664 Q46861116-43B67D7F-4EE8-4A01-B79C-C5109D18D988 Q49422874-688A461A-3B7D-4EBA-B42E-20CAD7882B12

P2860

An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity

http://www.wikidata.org/entity/Q28275948

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

An RNA profile identifies two ...... differing in disease activity

@ast

An RNA profile identifies two ...... differing in disease activity

@en

An RNA profile identifies two ...... differing in disease activity

@nl

type

label

An RNA profile identifies two ...... differing in disease activity

@ast

An RNA profile identifies two ...... differing in disease activity

@en

An RNA profile identifies two ...... differing in disease activity

@nl

prefLabel

An RNA profile identifies two ...... differing in disease activity

@ast

An RNA profile identifies two ...... differing in disease activity

@en

An RNA profile identifies two ...... differing in disease activity

@nl

P1433

Q28275948-087F3FF2-8B77-45B2-B0DE-3D0EFF6FA87B

P1476

Q28275948-9FF0CA64-F31B-460C-83FF-F40905C03B18

P2093

Q28275948-283D2297-FFA3-47E3-A5B2-F8D43652B339

Q28275948-6AFEAD1C-AFD1-42CD-81E9-A717E67DE0F6

Q28275948-9B3CE9D0-E58D-4E71-8F81-3F7D8868C129

Q28275948-B2104E84-C7D5-452D-A635-C7116C3DF29E

Q28275948-DB1503D6-06D2-45B6-A712-A72F8A78004E

P2860

Q28275948-029DD09A-6D6E-4DF0-8129-FE7677D0B38C

Q28275948-0EC5A4F9-E982-4300-A2BF-ECFED5F187B3

Q28275948-185E713C-9D9C-46DA-A6F0-BA2B975ADF3E

Q28275948-1898FBF9-4C39-42ED-9DA0-D0BED74E1431

Q28275948-289EB074-BCBC-413F-86A7-F6A1CA472638

Q28275948-38206CF1-5821-4A36-B599-4C8ECB736F3E

Q28275948-4F9E1326-16FE-4C77-BA85-775848D786D9

Q28275948-590D8F84-FA75-471F-9535-1F369C5961A7

Q28275948-816F9845-9F95-4296-A1B3-4930B59D80E0

Q28275948-857A2138-5487-4C81-A843-3BCE653E26B9

P304

Q28275948-A535061B-1F98-4FE3-A7B5-8F488133A219

P31

Q28275948-D5002E9E-AB0C-4DF3-AF77-FD9A8DAB4FCE

P3181

Q28275948-F6E22BED-DDD5-4BC5-8063-2F3B7AA398B9

P356

Q28275948-001F2361-C78F-4C26-8F14-B1923E0D3835

P407

Q28275948-5F4824D5-4FA3-414B-9BB8-CA15B79E0525

P433

Q28275948-821A4514-7233-4E31-9478-E7BE7E8144C3

P478

Q28275948-421BEEE8-65DC-40A5-A9F4-C97DAB9346CC

P50

Q28275948-7D75267F-FD42-40A9-92CD-87DA7C87DBC4

Q28275948-DA3142B4-443F-448F-A7E2-E8467E3074D6

Q28275948-DABDCC2E-89A5-474C-90EF-ECA67ACE6112

Q28275948-F5D10CDE-1893-431B-ADF7-39EA0268F830

Q28275948-FAA5EC8D-C79D-4BA2-BDAE-911E4D07FCFD

P577

Q28275948-73D1B2B7-CDFE-47FE-AEE0-EB56CA110F26

P5875

Q28275948-650F9AF5-F160-4447-BAE1-1DAE5B35E88A

P698

Q28275948-4FA946EB-03C1-44DA-AF90-3C6BABA16F67

P921

Q28275948-45D40901-A19A-4501-AF96-480B0ABEA57A

P932

Q28275948-2DF7405C-A24A-4EC0-94A3-EC97F8ABC4F1

P3181

P356

SCITRANSLMED.3004186

P1433

Science Translational Medicine

P1476

An RNA profile identifies two ...... differing in disease activity

@en

P2093

Brendan T Keenan

http://www.w3.org/2001/XMLSchema#string

Guy J Buckle

http://www.w3.org/2001/XMLSchema#string

Manik Kuchroo

http://www.w3.org/2001/XMLSchema#string

Pablo Tamayo

http://www.w3.org/2001/XMLSchema#string

Philip L De Jager

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Transcription-based prediction of response to IFNbeta using supervised computational methods

Learning the parts of objects by non-negative matrix factorization

A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis

GenePattern 2.0

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score.

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.

P304

153ra131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

777038

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCITRANSLMED.3004186

http://www.w3.org/2001/XMLSchema#string

P407

P433

153

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Jill P. Mesirov

Howard L. Weiner

David A. Hafler

P577

2012-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231225780

http://www.w3.org/2001/XMLSchema#string

P698

23019656

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

3753678

http://www.w3.org/2001/XMLSchema#string